Jessica Kearney, NP
Primary Care · Oklahoma City, OKNPI 1700492618
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,184 of the $4,697 with a category attached, or 67.8%. Medtronic accounts for 62.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $2,782 and has fallen 74.7% since, to $704 in 2025. Among primary care clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 133 payments — averaging $35.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- GRT US Holding, Inc.$626
- Averitas Pharma Inc.$495
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$187
- Organogenesis Inc.$125
- Forte Bio-pharma LLC$87
- plus $241 from 5 others
What the payments were for
- Travel & lodging$1,46831%
- Food & beverage$3,18468%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 56 | $2,938 |
| GRT US Holding, Inc. | 26 | $626 |
| Averitas Pharma Inc. | 24 | $495 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $187 |
| Organogenesis Inc. | 1 | $125 |
| Forte Bio-pharma LLC | 5 | $87 |
| Collegium Pharmaceutical, Inc. | 4 | $70 |
| Vertex | 3 | $61 |
| Valinor Pharma, LLC | 3 | $57 |
| SPR Therapeutics, Inc | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,397
- INTELLIS ADAPTIVESTIM$272
- Qutenza$220
- PuraPly$125
How this compares
$4,697 in reported general payments places this provider in the 90th percentile of 83 primary care providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 51 | $40,662 |
| Buprenorphine | 64 | $17,803 |
| LinzessLinaclotide | 17 | $9,119 |
| BelsomraSuvorexant | 20 | $8,374 |
| MovantikNaloxegol Oxalate | 17 | $6,827 |
| Lidocaine | 44 | $4,074 |
| Gabapentin | 300 | $4,064 |
| Pregabalin | 167 | $2,855 |
| Tizanidine Hcl | 244 | $2,736 |
| Cyclobenzaprine Hcl | 172 | $1,993 |
| Tramadol Hcl | 101 | $1,739 |
| Tramadol Hcl ErTramadol Hcl | 20 | $1,296 |
| Diclofenac Sodium | 28 | $1,006 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 34 | $927 |
| Methocarbamol | 46 | $848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $70 | $40,66251 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 83 primary care providers in Oklahoma.
Other primary care in Oklahoma City
- Misty DeanOklahoma City$6K
- Erin OlmstedOklahoma City$3K
- Divya JoykuttyOklahoma City$3K
- Kathy SpeigelOklahoma City$1K
- Kimberly AllenOklahoma City$1K
- Mandi BrownOklahoma City$978
- Thomas CookOklahoma City$792
- Krystal RachalOklahoma City$704
- Kendra BondOklahoma City$488
- Janice GuthrieOklahoma City$220
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.